Literature DB >> 21813638

Roles of FGF19 in liver metabolism.

S Kir1, S A Kliewer, D J Mangelsdorf.   

Abstract

Fibroblast growth factor 19 (FGF19) is an ileum-derived postprandial enterokine that governs bile acid and nutrient metabolism. Synthesis of FGF19 is up-regulated by bile acids and, conversely, bile acid synthesis is down-regulated by FGF19. FGF19 also controls gallbladder volume. FGF19 has been shown to have profound effects on glucose and lipid metabolism. Recent studies have described FGF19 as a postprandial regulator of hepatic glucose and protein metabolism. Like insulin, FGF19 induces protein and glycogen synthesis and suppresses gluconeogenesis in liver. However, unlike insulin, FGF19 does not stimulate lipogenesis. A key difference between FGF19 and insulin lies in their use of different cellular signaling pathways. The beneficial effects of FGF19 on liver metabolism raise the question of whether FGF19 and its variants can be used as therapeutic agents in the treatment of diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813638     DOI: 10.1101/sqb.2011.76.010710

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  54 in total

Review 1.  The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes.

Authors:  Randy J Seeley; Adam P Chambers; Darleen A Sandoval
Journal:  Cell Metab       Date:  2015-02-05       Impact factor: 27.287

Review 2.  Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?

Authors:  Rohit Kohli; Andriy Myronovych; Brandon K Tan; Rosa-Maria Salazar-Gonzalez; Lili Miles; Wujuan Zhang; Melissa Oehrle; Darleen A Sandoval; Karen K Ryan; Randy J Seeley; Kenneth D R Setchell
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 3.  FGFR4: A promising therapeutic target for breast cancer and other solid tumors.

Authors:  Kevin M Levine; Kai Ding; Lyuqin Chen; Steffi Oesterreich
Journal:  Pharmacol Ther       Date:  2020-05-31       Impact factor: 12.310

4.  Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.

Authors:  Ekaterina S Kuzina; Peter Man-Un Ung; Jyotidarsini Mohanty; Francisco Tome; Jungyuen Choi; Els Pardon; Jan Steyaert; Irit Lax; Avner Schlessinger; Joseph Schlessinger; Sangwon Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

Review 5.  Fibroblast growth factors 19 and 21 in acute liver damage.

Authors:  Zhao Shan; Gloria Alvarez-Sola; Iker Uriarte; María Arechederra; Maite G Fernández-Barrena; Carmen Berasain; Cynthia Ju; Matías A Avila
Journal:  Ann Transl Med       Date:  2018-06

Review 6.  The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery.

Authors:  Farnaz Fouladi; James E Mitchell; Joseph A Wonderlich; Kristine J Steffen
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

Review 7.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

8.  FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.

Authors:  Saachi Sachdev; Qi Wang; Charles Billington; John Connett; Leaque Ahmed; William Inabnet; Streamson Chua; Sayeed Ikramuddin; Judith Korner
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

Review 9.  Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery.

Authors:  J David Mosinski; John P Kirwan
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

10.  Dose of Phenobarbital and Age of Treatment at Early Life are Two Key Factors for the Persistent Induction of Cytochrome P450 Enzymes in Adult Mouse Liver.

Authors:  Yun-Chen Tien; Ke Liu; Chad Pope; Pengcheng Wang; Xiaochao Ma; Xiao-bo Zhong
Journal:  Drug Metab Dispos       Date:  2015-09-23       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.